Effects of Ido1 on mouse decidualization

被引:0
|
作者
D.-D. Li
Y.-H. Yin
J.-Y. Wu
Z.-Q. Yang
H. Cao
Q.-L. Zhang
B. Guo
Z.-P. Yue
机构
[1] Jilin University,College of Veterinary Medicine
[2] Guizhou Minzu University,Department of Laboratory Medicine
[3] General Hospital of Jinan Military Region of PLA,undefined
来源
Molecular Biology | 2015年 / 49卷
关键词
Ido1; decidualization; uterus; mouse;
D O I
暂无
中图分类号
学科分类号
摘要
Indoleamine 2,3-dioxygenase 1 (Ido1) is a rate-limiting enzyme which converts the essential amino acid tryptophan to kynurenine. The aim of this study was to investigate the expression and regulation of Ido1 in mouse uterus during decidualization. The results showed that Ido1 mRNA expression gradually increased from day 1 to 4 of pregnancy and reached the peak level on day 4. On days 5–8 of pregnancy, a low level of Ido1 expression was observed in the uteri. Simultaneously, Ido1 mRNA was also lowly expressed in the decidualized uterus and the stromal cells treated with 8-Br-cAMP. Under in vitro decidualization, the expression of Ido1 mRNA gradually declined. Further studies found that overexpression of Ido1 can inhibit the expression of decidualization marker genes PRL, IGFBP1 and Dtprp under in vitro decidualization while inhibition of Ido1 with L-1-MT can induce the expression of these marker genes. Ido1 can prevent uterine stromal cells proliferation and enhance the expression of the Bax gene and increase the Bax/Bcl2 ratio under in vitro decidualization. Additionally, Ido1 can also modulate the expression of the MMP2 gene. In the uterine stromal cells, estrogen and progesterone can stimulate the expression of Ido1. These data indicate that Ido1 may play an important role during mouse decidualization and may be regulated by estrogen and progesterone in the uterine stromal cells.
引用
收藏
页码:581 / 588
页数:7
相关论文
共 50 条
  • [21] Superiority of dual IDO1/TDO2 inhibition versus IDO1 selective inhibition in reducing immunosuppressive KYN levels in tumors co-expressing IDO1 and TDO2
    Lotz-Jenne, Carina
    Cren, Sylvaine
    Joesch, Christoph
    Ackerknecht, Sabine
    Brandes, Jennifer
    Moebs, Claire
    Hartl, Dominik
    Hartrampf, Felix
    Guerry, Philippe
    Pothier, Julien
    Chavanton-Arpel, Alexia
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (12)
  • [22] Development of a DNA aptamer targeting IDO1 with anti-tumor effects
    Zhu, Zhenyu
    Yang, Zeliang
    Zhu, Chuanda
    Hu, Zixi
    Jiang, Zhongyu
    Gong, Jingjing
    Yuan, Yuyao
    Chen, Xi
    Jin, Yan
    Yin, Yuxin
    ISCIENCE, 2023, 26 (08)
  • [23] Impact of IDO1 and IDO2 on the B Cell Immune Response
    Merlo, Lauren M. F.
    Peng, Weidan
    Mandik-Nayak, Laura
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma
    Orecchini, E.
    Belladonna, M. L.
    Pallotta, M. T.
    Volpi, C.
    Zizi, L.
    Panfili, E.
    Gargaro, M.
    Fallarino, F.
    Rossini, S.
    Suvieri, C.
    Macchiarulo, A.
    Bicciato, S.
    Mondanelli, G.
    Orabona, C.
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [25] Amyloid β neurotoxicity is IDO1-Kyn-AhR dependent and blocked by IDO1 inhibitor
    Duan, Zhenzhen
    Zhang, Shengnan
    Liang, Heng
    Xing, Zikang
    Guo, Leilei
    Shi, Lei
    Du, Lisha
    Kuang, Chunxiang
    Takikawa, Osamu
    Yang, Qing
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [26] GS-4361: A novel IDO1 Inhibitor
    Kalla, Rao
    Elbel, Kristy
    Bartlett, Mark
    Cosman, Jennifer
    Perry, Thao
    Elzein, Elfatih
    Li, Xiaofen
    Koltun, Dmitry
    Parkhill, Eric
    Zablocki, Jeff
    Clark, Mike
    Maecker, Heather
    Jawahar, Sudhamsu
    Hendricks, Deborah
    Shornikov, Alex
    Koditek, David
    Stafford, Brian
    Soohoo, Daniel
    Voigt, Johannes
    Lansdon, Eric
    Mackman, Richard
    Corkey, Britton
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [27] IDO1 INVOLVEMENT IN MEDULLOBLASTOMA: A POSSIBLE INTERACTION WITH mTOR
    Folgiero, Valentina
    del Bufalo, Francesca
    Carai, Andrea
    Cefalo, Maria Giuseppina
    Citti, Arianna
    Rutella, Sergio
    Locatelli, Franco
    Mastronuzzi, Angela
    NEURO-ONCOLOGY, 2014, 16 : 141 - 141
  • [28] IDO1 as a potential diagnostic biomarker for gastric cancer
    Wang, Yulu
    Jin, Yun
    Wang, Tongyu
    Zhou, Ning
    ASIAN JOURNAL OF SURGERY, 2024, 47 (10) : 4351 - 4353
  • [29] IDO1: An important immunotherapy target in cancer treatment
    Li, Fangxuan
    Zhang, Rupeng
    Li, Shixia
    Liu, Juntian
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 47 : 70 - 77
  • [30] ROCHE AND CURADEV SIGN IDO1/TDO PACT
    不详
    CHEMICAL & ENGINEERING NEWS, 2015, 93 (17) : 15 - 15